Figure 1From: Detection of Circulating Tumor Cells in Prostate Cancer Patients: Methodological Pitfalls and Clinical RelevanceAn example of a multiplex PCR protocol for the detection of prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA), prostate stemcell antigen (PSCA), parathyroid hormone-related protein (PTHrP), and cytokeratin 19 (CK19) mRNA in a peripheral blood sample from a prostate cancer patient. Lane M, size markers; lane A, sample from prostate cancer patient with metastatic disease; lane B, sample from healthy young male (negative control).Back to article page